ArticleeLife2021

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy.

Alexander O Pasternak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.